OPENDOOR PUBLISHING LIMITED
Company number 12939832 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
OPENDOOR PUBLISHING LIMITED - Analysis Report
Company Number: 12939832
Analysis Date: 2025-07-29 14:36 UTC
Financial Health Assessment Report for Opendoor Publishing Limited
1. Financial Health Score: D
Explanation:
The company shows clear signs of financial distress, with persistent net liabilities, negative working capital, and diminishing cash reserves. While it remains operational with director and parent company support, the financial "vital signs" indicate weakness and risk, warranting a cautious and proactive approach to recovery.
2. Key Vital Signs
Net Current Assets (Working Capital):
- 2023: £-6,819
- 2022: £-3,494
Negative working capital indicates the company’s short-term liabilities exceed its short-term assets, a symptom akin to a patient struggling to meet immediate obligations, risking liquidity crisis.
Net Assets (Shareholders’ Funds):
- 2023: £-6,464
- 2022: £-2,958
The company is in a net liabilities position, meaning total liabilities exceed total assets. This is comparable to a weakened immune system, reflecting accumulated losses and erosion of equity.
Cash Reserves:
- 2023: £158
- 2022: £4,898
A sharp decline in readily available cash is a critical symptom of liquidity stress, akin to a person losing hydration and energy reserves.
Debtors and Creditors:
- Debtors decreased from £5,651 (2022) to £3,833 (2023), indicating some reduction in receivables.
- Creditors decreased from £14,043 (2022) to £10,810 (2023), but still represents significant short-term obligations.
The company appears to be managing payables and receivables, but the balance sheet shows that liabilities still outweigh assets.
Share Capital:
- Remains minimal at £100, indicating limited capital buffer.
Going Concern Note:
The directors note the company is supported by its parent and directors, which is a vital external "lifeline" sustaining operations despite financial weakness.
3. Diagnosis
The company is experiencing symptoms typical of financial distress: negative working capital, net liabilities, and severely reduced cash on hand. The deterioration from 2022 to 2023 indicates worsening liquidity and solvency conditions. Although no formal insolvency procedures are underway, the company is at risk of cash flow strain which, if untreated, could escalate to default on obligations.
The underlying causes appear to be accumulated operational losses (reflected in retained earnings), potentially insufficient profitability or cash generation from publishing activities, and reliance on related party funding. The company functions with a very small capital base and limited liquidity, making it vulnerable to external shocks or operational setbacks.
4. Recommendations
To restore financial wellness and avoid progressing toward crisis, the company should:
Improve Cash Flow Management:
Prioritize accelerating debtor collections and negotiating extended payment terms with creditors. Cash flow is the "heartbeat" of financial health; stabilizing it is critical.Review Cost Structure:
Conduct a thorough expense audit to identify and cut non-essential costs, improving operational efficiency and reducing burn rate.Increase Capital Buffer:
Consider capital injection from shareholders or parent company to strengthen equity and working capital, improving solvency ratios.Enhance Financial Reporting:
Prepare and review income statements and cash flow forecasts to identify profit drivers and cash flow patterns for timely decision-making.Explore Revenue Growth Opportunities:
Innovate publishing offerings or expand market reach to increase sales, which will improve both profitability and liquidity.Engage Professional Advice:
Seek financial advisory support for turnaround strategies, refinancing options, or restructuring if necessary.
Medical Analogy Summary:
Opendoor Publishing Ltd is currently in a state of financial "illness" characterized by symptoms of liquidity shortage and equity depletion. While the company is "still breathing" thanks to external support, without prompt intervention to restore the "circulatory system" of cash flow and "immune system" of capital, the risk of severe financial collapse remains high.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.